• Physician Profile

    Lisa R. Diller, MD

     
    Lisa R. Diller, MD

    Top Doctor

     
    Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Clinical Director, Pediatric Oncology
    Medical Director, Clinical Cancer and Blood Disorders Service Line
    Medical Director, David B. Perini, Jr. Quality of Life Clinic


    Professor of Pediatrics, Harvard Medical School

    Centers/Programs

    Pediatric Solid Tumors
    Pediatric Cancer Survivorship

    Office phone: 617-632-5642
    Appointment phone: 617-632-5508
    Fax: 617-582-9049
    Email: lisa_diller@dfci.harvard.edu

    Preferred contact method: office phone
    Request an appointment

    View Researcher Profile
     
     

    Discipline

    Pediatric Hematologist/Oncologist

    Research Department

    Pediatric Oncology

    Interests

    Late effects of pediatric cancer, Retinoblastoma, Solid tumors, Wilms tumor, Neuroblastoma, Cancer predisposition


    Dana-Farber Cancer Institute
    450 Brookline Avenue
    Boston, MA 02215

    Biography

    Dr. Lisa Diller is the Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center. As a pediatric oncologist and the Clinical Director of Pediatric Oncology, she leads the joint clinical Pediatric Oncology Program at the Dana-Farber Cancer Institute and Boston Children's Hospital. She is also the Director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelors degree from Harvard University, and earned her medical degree from the University of California at San Diego. She was a resident at Boston Children's Hospital and did her subspecialty training at Boston Children's Hospital/Dana-Farber Institute where she has been on the faculty for more than 20 years. Dr. Diller's research focuses on the late effects of treatment for childhood cancer and genetic cancer predisposition syndromes in childhood. In addition, she investigates novel treatments for pediatric solid tumors, particularly tumors that occur in infants and toddlers.

    Background

    Board Certification
    Pediatric Hematology/Oncology
    Pediatrics

    Fellowship
    Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 07/88 to 06/91

    Residency
    Boston Children's Hospital, Pediatrics, 07/86 to 06/88

    Internship
    Children's Hospital Boston, 07/85 to 06/86

    Medical School
    University of California, San Diego School of Medicine, 1985

    Recent Awards

    • Stephen E. Sallan Leadership award, 2004
    • Benacerraf-Frei Investigator, DFCI, 1998
    • Dyson Scholar Award, DFCI, 1998